New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients Notified - ---
TestMu AI Launches Test Deduplication Agent to Clean Up Test Repositories Bloated by AI-Generated Test Cases Notified -
M/Y Dagger joins the SEA Index®: HSH Prince Albert II discovers Benetti’s new hybrid yacht Notified -
Descartes Expands AI Innovation with Agent that Helps Reduce Global Trade Data Research and Analysis Time by Up to 90% Notified -
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health Notified -
Wood Mackenzie: Europe's Power Sector Hits 80% Zero-Carbon Generation by 2030, But Misses Its Own Renewables Target Notified -
52% of business travelers prioritize security when companies provide their connection, according to Holafly for Business Notified -
Long Hours, Changing Postures: Sihoo to Showcase Next-Generation Ergonomic Office Chairs at ORGATEC 2026 Notified -
ERS electronic Unveils Fully Automated 310 x 310 mm Panel-Level Packaging System to Power AI and Chiplet Architectures Notified -
Bodor Laser Marks 10,000-Machine Milestone, Turning Manufacturing Scale into Customer Value Notified -
Univar Solutions Strengthens North American Beauty and Personal Care Portfolio with Exclusive CABB Group Glycolic Acid Distribution Partnership Notified -
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab) Notified -
Hong Kong Tourism Board Makes Monaco Yacht Show Debut to Showcase Ambition as Asia's Leading Yacht Tourism and Marine Business Hub Notified -